✦ LIBER ✦

M3 muscarinic receptors as targets for drug development in neurodegenerative disorders

✍ Scribed by Dragunow, Mike

Book ID: 109950494
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 107 KB
Volume: 7
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrd2506-c1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The M5 muscarinic receptor as possible t

The M5 muscarinic receptor as possible target for treatment of drug abuse

✍ R. B. Raffa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

GABA receptors and GABAergic synapses as

GABA receptors and GABAergic synapses as targets for drug development

✍ Charles P. Taylor 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

Gamma-amino butyric acid (GABA) is perhaps the most abundant and important rapid inhibitory neurotransmitter in the mammalian brain. Many previous studies have indicated that GABAergic synapses are involved in drug treatments or disease processes for epilepsy, anxiety, movement disorders, depression

Treatments for behavioural disorders in

Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies

✍ Cummings, Jeffrey L.; Zhong, Kate 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 352 KB

Adenosine receptors: novel targets for d

Adenosine receptors: novel targets for drug development in allergic rhinitis

✍ M. G. Matera; R. Polosa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Neurokinin NK1 and NK3 receptors as targ

Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain

✍ Gareth J Sanger 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 243 KB

Distribution of GABAA and GABAB receptor

Distribution of GABAA and GABAB receptors in mammalian brain: Potential targets for drug development

✍ Anne B. Young; Dorothy Chu 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB